Učitavanje...
培美曲塞治疗全身化疗和吉非替尼治疗失败的肺腺癌32例临床观察
BACKGROUND AND OBJECTIVE: The relapse-free time of gefitinib as the second or third line therapy in patients with advanced non-small cell lung cancer (NSCLC) was not satisfactory. The aim of this study is to evaluate the efficacy and toxicity of pemetrexed in patients with pulmonary adenocarcinoma a...
Spremljeno u:
| Izdano u: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
中国肺癌杂志编辑部
2010
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000551/ https://ncbi.nlm.nih.gov/pubmed/20704823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2010.08.11 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|